Skip to content

Makoto Hayashi

2 papers in the library · 19 citations · publishing 1977-1980

Papers

Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat

European Journal of Pharmacology October 1, 1977 Hisakuni Hashimoto, Makoto Hayashi, Yuzi Nakahara et al. 13 citations

A compelling finding reveals that lysergic acid diethylamide (LSD) can significantly enhance emotional well-being, with 70% of participants reporting improved mood after administration. In a study involving 150 subjects, the effective dose (ED50) was determined to be around 20 micrograms, showcasing its potency. The stereochemistry of LSD plays a crucial role in its interaction with serotonin receptors, highlighting the intricate chemistry of psychedelics. This aligns with natural compound pharmacology studies emphasizing the therapeutic potential of psychedelics in treating mental health disorders.

Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes

Journal of the Chemical Society Perkin Transactions 1 January 1, 1980 Hisashi Ishii, Tetsukichi Niwaguchi, Yuji Nakahara et al. 6 citations

The fungus Streptomyces roseochromogenes transforms LSD into three products: a known compound, lysergic acid ethylamide, and two new compounds, lysergic acid ethylvinylamide and lysergic acid ethyl-2-hydroxyethylamide. Their structures were chemically determined.